Provided by Tiger Trade Technology Pte. Ltd.

Medpace

455.15
+1.510.33%
Post-market: 455.150.00000.00%17:04 EDT
Volume:326.66K
Turnover:149.09M
Market Cap:12.92B
PE:29.79
High:466.17
Open:457.75
Low:451.06
Close:453.64
52wk High:628.92
52wk Low:250.05
Shares:28.38M
Float Shares:22.22M
Volume Ratio:0.93
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.28
EPS(LYR):15.28
ROE:70.23%
ROA:16.40%
PB:28.14
PE(LYR):29.79

Loading ...

Jul 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 22, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 21, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 22, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 22, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2025

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 21, 2024

Major Issues Report

Form 8-K - Current report
Aug 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities